RBM15 and breast carcinoma: In summary, RBM15 drives breast cancer progression by promoting metabolic reprogramming, stabilizing oncogenic transcripts, and conferring chemotherapy resistance, thereby representing a crucial therapeutic target in aggressive breast cancer subtypes.